Rq. Yan et al., HUMAN HEPATITIS-B VIRUS AND HEPATOCELLULAR-CARCINOMA .1. EXPERIMENTAL-INFECTION OF TREE SHREWS WITH HEPATITIS-B VIRUS, Journal of cancer research and clinical oncology, 122(5), 1996, pp. 283-288
Tree shrews (Tupaia belangeri chinenesis) can be experimentally infect
ed with human hepatitis B virus (HBV) by inoculation with human serum
positive for HBV, the experimental infection rate being 55.21%. Succes
sive infections have been passed through five generations among the tr
ee shrews inoculated with HBV-positive sera from the infected animals,
the average infection rate being 94.0%. The experimental infection of
tree shrews with HBV may be prevented by immunization with hepatitis
B vaccine, the protection rate being 88.89%. Standard serum containing
HBV at 10(8) CID (chimpanzee infection dose)/ml, was diluted 10(-6),
10(-7), 10(-8), 10(-9), and 10(-10) and produced infection rates of 80
.0%, 88.8%, 66.7%, 55.6% and 42.9% respectively. Thus the CID50 in tre
e shrews may reach a dilution of 10(-9), which shows that tree shrews
are sensitive to HBV infection. These results successfully establish t
ree shrews as a reliable and useful animal model for research on HBV i
nfection and its relation to hepatocarcinogenesis.